Alzheimer’s disease is currently the third-leading cause of death among seniors in the U.S., following cardiovascular disease ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found ...

A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study led by Western researchers suggests that frequent treatment with intranasal o ...

Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone reverses it. That dismal lack of progress is partly because of the infinite ...

Gavin Patterson joins Alzheimer's Research UK as chair. The former President and Chief Revenue Officer of Salesforce and CEO ...

New research suggests that commonly used medications like antibiotics, antivirals, and anti-inflammatories could lower the ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

An inert and unreactive gas may not seem like an obvious candidate for treating Alzheimer's disease, yet a new study in mice ...

ATx has created groundbreaking drugs for dementia and Alzheimer’s. The Icelandic startup just raised €26mn to advance the ...

Margie Shaver has been advocating for Alzheimer’s research funding for 20 years. When she heads to Richmond on Thursday ...

Cure Alzheimer's Fund announced today that six scientists specializing in Alzheimer's disease and related research have joined its Research Leadership Group (RLG). The expertise and active ...